09:15 AM EDT, 04/29/2025 (MT Newswires) -- NeoGenomics ( NEO ) reported Q1 breakeven adjusted earnings Tuesday, compared to a loss of $0.02 per diluted share a year earlier.

Analysts polled by FactSet expected a loss of $0.01.

Net revenue for the quarter ended March 31 was $168 million, up from $156.2 million a year earlier.

Analysts surveyed by FactSet expected $170.6 million.

The company said it now expects 2025 adjusted diluted EPS of $0.16 to $0.20. That compares with $0.15 to $0.19 previously. Analysts surveyed by FactSet expect $0.19.

Consolidated revenue for the current year is now projected to be $747 million to $759 million, up from its prior outlook of $735 million to $745 million, the company said. Analysts polled by FactSet expect $739.2 million.

NeoGenomics ( NEO ) shares were down 3.6% in recent premarket activity Tuesday.